Morning Market Movers: Biotech Surges, Tech Stumbles
Olema Pharmaceuticals and Roche staged synchronized rallies after positive Phase III trial data, demonstrating biotech's continued volatility-driven potential. Barrick Gold attracted activist attention while Airbus capitalized on aerospace demand with a new order.
Tech faced headwinds as Cloudflare's outage punished shares and Roblox failed to capitalize on child safety updates. PDD Holdings' mixed earnings reminded markets of e-commerce's uneven recovery, while Salesforce's Informatica acquisition signaled renewed consolidation appetite.
Rivian's analyst-driven surge contrasted sharply with Honeywell's downgrade, highlighting the market's selective risk appetite. Can-Fite BioPharma's liver cancer treatment breakthrough delivered outsized returns for speculators - a reminder of biotech's binary payoff structure.
